PedAM
Pediatric Disease Annotations & Medicines
| Disease | diarrhea |
| Phenotype | C0007131|nsclc |
| Sentences | 2 |
| PubMedID- 25960692 | [14] found that there was a strong association between the abcg2 421 c/a polymorphism and diarrhea in nsclc patients treated with gefitinib. |
| PubMedID- 24261963 | Though buparlisib in combination with geftinib was found to be safe, high frequency of severe late toxicities, including rash and diarrhea was noted in patients with egfr tki-resistant nsclc in a phase ib study, and alternative dosing schedules are thus warranted in subsequent studies [109]. |
Page: 1